“Why do some adults with PiMZ apha1-antitrypsin develop bronchiectasis?”

Nupur Aggarwal, Beatriz Martinez Delgado, Sandeep Salipalli, Nerea Matamala, Jessica Rademacher, Nicolaus Schwerk, Tobias Welte, Sabina Janciauskiene and Felix C. Ringshausen

Source: ERJ Open Res 2016: 50021-2016-ERR
Journal Issue: July

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nupur Aggarwal, Beatriz Martinez Delgado, Sandeep Salipalli, Nerea Matamala, Jessica Rademacher, Nicolaus Schwerk, Tobias Welte, Sabina Janciauskiene and Felix C. Ringshausen. “Why do some adults with PiMZ apha1-antitrypsin develop bronchiectasis?”. ERJ Open Res 2016: 50021-2016-ERR

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Why do some adults with PiMZ a1-antitrypin develop bronchiectasis?
Source: ERJ Open Res 2016: 00021-2016
Year: 2016



What does healthy people know about asthma?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011


Self-management support for asthma and airways disease – what do patients want?
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2
Year: 2020


Why do adolescents grow out of their asthma?
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010

What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003

What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021


Is bronchiectasis really a disease?
Source: Eur Respir Rev, 29 (155) 190051; 10.1183/16000617.0051-2019
Year: 2020



What is COPD? What is asthma?
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

How many young adults are at risk of COPD?
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002

How children with asthma breathe: have we been overlooking a problem?
Source: Eur Respir J 2013; 41: 1008-1009
Year: 2013


Is there an association between tracheomalacia and bronchiectasis in children?
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



Undiagnosed coeliac disease in patients with emphysema: a fortuitous association?
Source: Eur Respir J 2010; 36: 453
Year: 2010


What do patients want? Preferences for two asthma regimens in mild/moderate asthma
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019


Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019


Chronic diseases like asthma and COPD: do they truly exist?
Source: Eur Respir J 2016; 47: 359-361
Year: 2016


Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021



How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013